Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Pett, SL"'
Autor:
Sy, A, McCabe, L, Hudson, E, Ansari, AM, Pedergnana, V, Lin, S-K, Santana, S, Fiorino, M, Ala, A, Stone, B, Smith, M, Nelson, M, Barclay, ST, McPherson, S, Ryder, SD, Collier, J, Barnes, E, Walker, AS, Pett, SL, Cooke, G, STOP-HCV-1 trial team
Background The CC genotype of the IFNL4 gene is known to be associated with increased Hepatitis C (HCV) cure rates with interferon-based therapy and may contribute to cure with direct acting antivirals. The Genedrive® IFNL4 is a CE marked Point of C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b034d625e97a98d9d47752054038efab
http://hdl.handle.net/10044/1/101914
http://hdl.handle.net/10044/1/101914
Autor:
Hung, R, Patel, N, Fox, J, Cosgrove, C, Pett, SL, Burns, F, Ustianowski, A, Rosenvinge, M, Bhagani, S, Dusheiko, G, Childs, K, Post, FA, GEN-AFRICA study group
Regional variability in the prevalence of hepatitis B (HBV) and C (HCV) is reported in sub-Saharan Africa, although data for people with HIV are sparse. We determined the prevalence of HBV/HCV in 2,473 people of African ancestry with HIV in the UK. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6f4f7c945610b407c38fe5d75d3940ab
Autor:
Burns, JE, Stöhr, W, Kinloch‐De Loes, S, Fox, J, Clarke, A, Nelson, M, Thornhill, J, Babiker, A, Frater, J, Pett, SL, Fidler, S
Publikováno v:
HIV Medicine; Sep2021, Vol. 22 Issue 8, p770-774, 5p
Autor:
Kityo, C, Szubert, AJ, Siika, A, Heyderman, R, Bwakura-Dangarembizi, M, Lugemwa, A, Mwaringa, S, Griffiths, A, Nkanya, I, Kabahenda, S, Wachira, S, Musoro, G, Rajapakse, C, Etyang, T, Abach, J, Spyer, MJ, Wavamunno, P, Nyondo-Mipando, L, Chidziva, E, Nathoo, K, Klein, N, Hakim, J, Gibb, DM, Walker, AS, Pett, SL, Mugyenyi, P, Musiime, V, Nambi, E, Ocitti, P, Ndigendawani, M, Kemigisa, M, Acen, J, Olebo, D, Mpamize, G, Amone, A, Okweny, D, Mbonye, A, Nambaziira, F, Rweyora, A, Kangah, M, Kabaswahili, V, Abongomera, G, Omongin, J, Aciro, I, Philliam, A, Arach, B, Ocung, E, Amone, G, Miles, P, Adong, C, Tumsuiime, C, Kidega, P, Otto, B, Apio, F, Baleeta, K, Mukuye, A, Abwola, M, Ssennono, F, Baliruno, D, Tuhirwe, S, Namisi, R, Kigongo, F, Kikyonkyo, D, Mushahara, F, Tusiime, J, Musiime, A, Nankya, A, Atwongyeire, D, Sirikye, S, Mula, S, Noowe, N, Kasozi, M, Mwebe, S, Atwine, L, Senkindu, T, Natuhurira, T, Katemba, C, Ninsiima, E, Acaku, M, Kyomuhangi, J, Ankunda, R, Tukwasibwe, D, Ayesiga, L, Reid, A, Mhute, T, Tinago, GC, Bhiri, J, Mudzingwa, S, Phiri, M, Steamer, J, Nhema, R, Warambwa, C, Mutsai, S, Nemasango, B, Moyo, C, Chitongo, S, Rashirai, K, Vhembo, S, Mlambo, B, Nkomani, S, Ndemera, B, Willard, M, Berejena, C, Musodza, Y, Matiza, P, Mudenge, B, Guti, V, Etyang, A, Agutu, C, Berkley, J, Maitland, K, Njuguna, P, Awuondo, K, Wale, S, Shangala, J, Kithunga, J, Mwarumba, S, Maitha, SS, Mutai, R, Lewa, ML, Mwambingu, G, Mwanzu, A, Kalama, C, Latham, H, Shikuku, J, Fondo, A, Njogu, A, Khadenge, C, Mwakisha, B, Wools-Kaloustian, K, Nyandiko, W, Cheruiyot, P, Sudoi, A, Meli, B, Karoney, M, Nzioka, A, Tanui, M, Mokaya, M, Ekiru, W, Mboya, C, Mwimali, D, Mengich, C, Choge, J, Injera, W, Njenga, K, Cherutich, S, Orido, MA, Lwande, GO, Rutto, P, Mudogo, A, Kutto, I, Shali, A, Jaika, L, Jerotich, H, Pierre, M, Mallewa, J, Kaunda, S, Van Oosterhout, J, O'Hare, B, Heydermann, R, Gonzalez, C, Dzabala, N, Kelly, C, Denis, B, Selemani, G, Mipando, LN, Chirwa, E, Banda, P, Mvula, L, Msuku, H, Ziwoya, M, Manda, Y, Nicholas, S, Masesa, C, Mwalukomo, T, Makhaza, L, Sheha, I, Bwanali, J, Limbuni, M
Background In sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%) shortly after starting antiretroviral therapy (ART). This group also has the greatest risk of morbidity and mortality a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::76c8634db5b063d7f9a222c5f8130b9d
http://hdl.handle.net/10044/1/90457
http://hdl.handle.net/10044/1/90457
Autor:
Pett, SL, Carey, C, Lin, E, Wentworth, D, Lazovski, J, Miró, JM, Gordin, F, Angus, B, Rodriguez-Barradas, M, Rubio, R, Tambussi, G, Cooper, DA, Emery, S
BACKGROUND AND OBJECTIVES: Bacterial pneumonia still contributes to morbidity/mortality in HIV infection despite effective combination antiretroviral therapy (cART). Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0317fb2dd21ac40d690a0f2ba94dfd6e
https://ora.ox.ac.uk/objects/uuid:21947913-ab15-4176-a1d4-e6661cc5f21f
https://ora.ox.ac.uk/objects/uuid:21947913-ab15-4176-a1d4-e6661cc5f21f
A retrospective clinical audit was performed to assess if the British HIV Association 2011 guidelines on routine screening for tuberculosis in HIV are being implemented in a large UK urban clinic, and if a tuberculosis-screening prompt on the electro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::2686f5b327fd8c7156c31201764cce47
Autor:
Pett, SL, Carey, C, Lin, E, Wentworth, D, Lazovski, J, Miró, JM, Gordin, F, Angus, B, Rodriguez-Barradas, M, Rubio, R, Tambussi, G, Cooper, DA, Emery, S
Bacterial pneumonia still contributes to morbidity/mortality in HIV infection despite effective combination antiretroviral therapy (cART). Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT), a trial of intermittent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de7d080070cc440427346e8f591d8f6b
https://europepmc.org/articles/PMC3048911/
https://europepmc.org/articles/PMC3048911/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.